For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.
Price · 1Y
$76.59
Thesis
Tempus AI builds a multimodal clinical and molecular data platform spanning diagnostics, genomic sequencing, and data licensing. Its scaled real-world datasets support both precision diagnostics and AI-enabled drug discovery partnerships.
Catalysts
- Genomics and diagnostics testing volume growth
- Data-licensing and pharma partnership expansion
- Margin progression as the platform scales
Recent events
Material filings, federal awards, and regulatory activity. Impact is scored against market cap.
- Sep 15M&ASEC
SEC Form 425 filing related to business combination.
- Aug 31M&ASEC
S-4 registration statement filed for merger or acquisition transaction.
- Jul 30Financial resultsSEC
8-K filing (items 2.02, 7.01, 9.01) disclosing results of operations and financial condition.
- Jul 20M&ASEC
SEC Form 425 filing for business combination.
- Jul 20M&ASEC
Tempus AI filed SEC Form 425 regarding a business combination.
- Jul 20M&ASEC
SEC Form 425 filing for business combination communications.
- Jul 20M&ASEC
SEC Form 425 filing for business combination communications.
- Jul 20M&ASEC
SEC Form 425 filing on business combination communications.